Top 5 Low Price Stocks To Invest In Right Now

Analysis focus: RARE

Ultragenyx (NASDAQ:RARE), which we recommended as a buy in October 2017 when it was trading at 52-week lows, has been up 50% since our recommendation. We recommended it on the basis of an upcoming approval of its Sly syndrome treatment MEPSEVII in November – which happened; and another approval of borosumab (Crysvita) in April – which also happened. We also liked its cash position, both then and now, and its sale of a Rare Disease Priority Review voucher for $130mn. We didn’t like its two trial failures from before, and its overpaid purchase of another drug company – but those were already factored into the low price, and the new catalysts, we assumed, would take the stock higher. This too, happened.

The latest news for RARE Is that its Crysvita showed that it could beat conventional therapy in pediatric patients with X-linked hypophosphatemia (XLH), an inherited form of rickets (vitamin D deficiency). These conventional therapies for this rare disease, with about 12,000 patients in the US, are oral phosphate and active vitamin D, which have been used traditionally to improve pediatric rickets. Borosumab demonstrated superiority to these therapies, as we would expect since its approval. The molecule is a “fully human recombinant monoclonla IgG1 antibody that binds to (inhibits) the phosphaturic hormone fibroblast growth factor 23 (FGF23), a hormone that reduces blood levels of phosphorus and active vitamin D by regulating phosphate excretion and active vitamin D production by the kidney.”

Top 5 Low Price Stocks To Invest In Right Now: Aphria Inc. (APHQF)

Advisors’ Opinion:

  • [By Cory Renauer]

    The North American Marijuana Index, which tracks the leading cannabis stocks in the U.S. and Canada, is right about where it was to start the year despite surging over the past few months of 2017. The same could be said for one of Canada’s larger growers. Aphria (NASDAQOTH:APHQF) stock has risen in recent weeks, but it’s still a bit below a peak it achieved in January. 

  • [By Sean Williams]

    According to BNN Bloomberg, Ontario-based Aphria (NASDAQOTH:APHQF) was, at one time, the apple of Coke’s eye. A source familiar with the matter notes that Coca-Cola held talks with senior management at Aphria a few months ago, but that no agreement was reached. The thing is, Aphria has just as much of a pedigree as a partner as Aurora Cannabis does. 

  • [By Keith Speights]

    Since we’re already talking about Aurora and Canopy, it makes sense to jump to the Canadian market next. Both companies are poised to enjoy tremendous sales growth with the opening of the Canadian recreational market. However, I’d put Aphria (NASDAQOTH:APHQF), Cronos Group (NASDAQ:CRON), and Tilray (NASDAQ:TLRY) on the list for top stocks for the Canadian market as well. Each of these three companies could also be major players in Germany alongside Aurora and Canopy.

  • [By Sean Williams]

    Right now, Cronos Group commands a market cap that’s just north of $1 billion. By comparison, Aphria (NASDAQOTH:APHQF) has 230,000 kilograms of fully funded capacity under construction, and it’s only valued at $1.6 billion. Aphria One and Aphria Diamond (the company’s joint venture with Double Diamond Farms) both dwarf Peace Naturals with respective annual yields of 100,000 kilograms and 120,000 kilograms. This is noteworthy since the cannabis industry often benefits from economies of scale. In other words, an increase in production usually leads to a decrease in costs, at least on a per-gram basis. 

  • [By Keith Speights]

    If year-to-date performance were the deciding factor on which stock to buy, there would be no contest between Aphria (NASDAQOTH:APHQF) and MariMed (NASDAQOTH:MRMD). Aphria has lost nearly half of its market cap. MariMed ranked as the best-performing marijuana stock of the first half of 2018. Its share price is now up more than 260% so far this year.

Top 5 Low Price Stocks To Invest In Right Now: Gaming and Leisure Properties, Inc.(GLPI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Janney Montgomery Scott LLC lifted its stake in Gaming and Leisure Properties Inc (NASDAQ:GLPI) by 13.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 22,286 shares of the real estate investment trust’s stock after acquiring an additional 2,564 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Gaming and Leisure Properties were worth $798,000 as of its most recent SEC filing.

  • [By Rich Duprey]

    Below is a mix of all of these types of companies. The stocks under my magnifying glass are Facebook (NASDAQ:FB), Macy’s (NYSE:M), and Gaming & Leisure Properties (NASDAQ:GLPI). Read on to see what’s wrong with two of these companies, and why the third one is a superior business.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Gaming and Leisure Properties (GLPI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Low Price Stocks To Invest In Right Now: VistaGen Therapeutics, Inc. (VTGN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Vistagen Therapeutics (NASDAQ:VTGN) was given a $6.00 price target by analysts at Oppenheimer Holdings Inc.. The firm currently has a buy rating on the stock.

  • [By Money Morning News Team]

    Take VistaGen Therapeutics Inc. (NASDAQ: VTGN) for example. While not necessarily a scam, this one didn’t do investors any favors.

    In Dec. 2017, shares jumped 177.17%, from $0.92 to $2.55 in just one day. Investors who bought at $2.55 ended up losing over 50% of their money when the stock quickly went back down to $1.05 in less than two weeks.

  • [By Money Morning News Team]

    For instance, VistaGen Therapeutics Inc. (Nasdaq: VTGN) shot up 177%, from $0.92 to $2.55, on Dec. 6, when it announced it won a patent for its CNS treatment.

Top 5 Low Price Stocks To Invest In Right Now: Ctrip.com International, Ltd.(CTRP)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Ctrip.com International (NASDAQ:CTRP) Q1 2018 Earnings Conference CallMay. 22, 2018 8:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Traders purchased shares of Ctrip.Com International Ltd (NASDAQ:CTRP) on weakness during trading hours on Tuesday. $83.84 million flowed into the stock on the tick-up and $38.29 million flowed out of the stock on the tick-down, for a money net flow of $45.55 million into the stock. Of all companies tracked, Ctrip.Com International had the 28th highest net in-flow for the day. Ctrip.Com International traded down ($1.32) for the day and closed at $49.90

  • [By Garrett Baldwin]

    Money Morning Special Situation Strategist Tim Melvin provides his latest list of stocks that will help you get rich… and stay rich. Check them out right here.

    Three Stocks to Watch Today: GE, AMZN, JD
    General Electric Co. (NYSE: GE) shares are under pressure after the stock received a downgrade from Swiss bank UBS Group AG (NYSE: UBS). The investment bank cut its price target for GE from $16 to $13. The bank cited ongoing struggles at GE’s power division as it continues to lose market share. Amazon.com Inc. (Nasdaq: AMZN) stock is on pace to overtake Apple Inc. (Nasdaq: AAPL) after it became the second company to achieve a $1 trillion market capitalization. The stock price has now doubled in a year thanks to its strong growth in retail sales and cloud computing. Apple needed 38 years to achieve the $1 trillion market cap while Amazon needed just 21 years. With that said, both AMZN and AAPL now comprise 8% of the entire S&P 500 market cap. Shares in JD.com Inc. (Nasdaq: JD) fell more than 5% in pre-market hours. Shares are on the decline after police said that its billionaire founder was arrested last week on charges of sexual assault. Look for additional earnings reports from Ctrip.com International Ltd. (Nasdaq: CTRP), Guidewire Software Inc. (Nasdaq: GWRE), Ollie’s Bargain Outlet Holdings Inc. (Nasdaq: OLLI), Vera Bradley Inc. (NYSE: VRA), and Verint Systems Inc. (Nasdaq: VRNT)

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ctrip.Com International (CTRP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Gramercy Property Trust (NYSE: GPT) rose 13.4 percent to $27.01 in pre-market trading after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    Warrior Met Coal, Inc. (NYSE: HCC) rose 9.1 percent to $30 in pre-market trading after climbing 5.61 percent on Friday.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 6.2 percent to $4.83 in pre-market trading after falling 48.35 percent on Friday.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 6 percent to $2.85 in pre-market trading after climbing 1.89 percent on Friday.
    Ctrip.com International, Ltd. (NASDAQ: CTRP) rose 4.8 percent to $43.15 in pre-market trading.
    G1 Therapeutics, Inc. (NASDAQ: GTHX) rose 3.2 percent to $44.00 in pre-market trading after climbing 6.92 percent on Friday.
    Synchrony Financial (NYSE: SYF) rose 3.2 percent to $33.68 in pre-market trading after gaining 2.03 percent on Friday.
    Starbucks Corporation (NASDAQ: SBUX) rose 3.1 percent to $59.45 in pre-market trading. Nestle announced plans to acquire rights to market, sell and distribute Starbucks Brands.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Top 5 Low Price Stocks To Invest In Right Now: MediWound Ltd.(MDWD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Mediwound (NASDAQ:MDWD) has been trending somewhat positive on Saturday, Accern Sentiment reports. Accern identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Mediwound earned a news impact score of 0.17 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 47.1925876006011 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Ethan Ryder]

    Mediwound (NASDAQ: MDWD) and True Drinks (OTCMKTS:TRUU) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

  • [By Money Morning Staff Reports]

    After looking at this week’s penny stock gainers, we’ll give you that leg up with one of our top-rated penny stocks from our proprietary stock ranking system…

    Penny Stock Current Share Price (March 26) Last Week’s Gain
    Cartesian Inc. (OTCMKTS: CRTN) $0.39 170.69%
    Odyssey Marine Exploration Inc. (Nasdaq: OMEX) $8.76 135.90%
    iFresh Inc. (Nasdaq: IFMK) $8.25 64.64%
    China Auto Logistics Inc. (Nasdaq: CALI) $4.68 47.43%
    National American University Holdings Inc. (Nasdaq: NAUH) $1.20 39.29%
    Document Security Systems Inc. (NYSE: DSS) $1.58 33.91%
    Blonder Tongue Labs Inc. (NYSE: BDR) $0.77 33.90%
    CareDx Inc. (Nasdaq: CDNA) $7.49 29.88%
    Mediwound Ltd. (Nasdaq: MDWD) $5.10 26.51%
    New York & Co. Inc. (NYSE: NWY) $3.37 26.35%

    Don’t Miss This Shot at a $78,000 Windfall: This tiny firm is about to make the entire world wire-free. As its game-changing technology revolutionizes the global power structure, its stock could hand investors a massive return. Learn more…

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Mediwound (MDWD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *